Content area


Præimplantationsgenetisk diagnostik

Biopsitagning. (Foto: Lene Pedersen).

Hans Jakob Ingerslev1, Birte Degn2, Christina Hnida1, Tue Diemer3, Michael Bjørn Petersen3, Tine Nørregaard Olesen1, Henrik Krarup2 & Inge Søkilde Pedersen2

1) Fertilitetsenheden, Aalborg Universitets-hospital 2) Afsnit for Molekylær Diagnostik, Aalborg Universitets-hospital 3) Klinisk Genetisk Afdeling, Aalborg Universitets-hospital Ugeskr Læger 2018;180:V09170692

Ugeskr Læger 2018;180:V09170692
Blad nummer: 
Preimplantation genetic diagnosis

In Denmark, preimplantation genetic diagnosis (PGD) is offered within the public healthcare to families with a known risk of an inherited disease in a child – as an alternative to prenatal diagnosis. It is a well-established technique with rather well-described perinatal- and neonatal outcomes, being comparable to what is seen following in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI). The most common strategy is now to perform trophectoderm biopsy and then vitrify, while the diagnostic test is performed. Until 2013, 134 children have been born following PGD. Today, the clinical pregnancy rates are comparable to those following IVF/ICSI.

Du skal være logget ind for at læse denne artikel
Log ind

Right side